Journal of Infection and Public Health

Papers
(The H4-Index of Journal of Infection and Public Health is 40. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Getting the counterfactual right: Estimating the cost per life saved of Covid-19 lockdown policies693
Isolation and characterizations of bacteriophages to treat multi-drug resistant bacterial infections186
The direct application of plasma droplet digital PCR in the ultra-early pathogen detection and warning during sepsis: Case reports166
Clinical pharmacy services in acute care setting during mass gatherings (Hajj): Insights from a task force159
Molecular epidemiology characteristics and detecting transmission of carbapenemase-producing enterobacterales in southwestern China148
Development and validation of artificial intelligence models to predict urinary tract infections and secondary bloodstream infections in adult patients139
Rate of shed of SARS COV-2 viral RNA from COVID-19 cadavers137
Reactivation of SARS-CoV-2 infection following recovery from COVID-19132
Differential expression of carcinoembryonic antigen-related cell adhesion molecule-5 (CEACAM5) and dipeptidyl peptidase‐4 (DPP4) with detection of Middle East respiratory syndrome-coronavirus in perip123
Lactate dehydrogenase and PaO2/FiO2 ratio at admission helps to predict CT score in patients with COVID-19: An observational study97
Heterologous vaccination (ChAdOx1 and BNT162b2) induces a better immune response against the omicron variant than homologous vaccination92
Editorial Board85
Hydroxychloroquine Pre-Exposure Prophylaxis for COVID-19 in Healthcare Workers from India: A Meta-Analysis82
The trends of mortality, aetiologies and risk factors of lower respiratory infections in China from 1990 to 2019: Findings from the Global Burden of Disease Study 201978
Association between human leukocyte antigen alleles and COVID-19 disease severity77
Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months74
Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia73
Antimicrobial stewardship programs in acute-care hospitals: A multicenter assessment of structure, process, and outcome indicators in Italy and Spain71
Changes in the spatiotemporal patterns of COVID-19 in Japan from 2020 through 202371
Time of developing surgical site infections and its association with patient and procedure characteristics70
Emergence of novel hypervirulent Acinetobacter baumannii strain and herpes simplex type 1 virus in a case of community-acquired pneumonia in China70
Relation between macrophage inflammatory protein-1 and intercellular adhesion molecule-1 and computed tomography findings in critically-ill saudi covid-19 patients70
Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation67
QcrB inhibition as a potential approach for the treatment of tuberculosis: A review of recent developments, patents, and future directions62
Mortality in Norway and Sweden during the COVID-19 pandemic60
CTLA-4 rs5742909 but not ADAM33 rs2280091 is a predictor factor for COVID-19 mortality57
The earliest case definition of suspected case of COVID-19 by WHO: Whether it was incomplete?57
A rare case report: Cutaneous Candida tropicalis infection disguised as a sacral decubitus rash in an immunocompetent individual56
Cost-effectiveness of improving patients’ adherence to tuberculosis treatment in South Korea using discrete event simulation56
High prevalence of anti-Strongyloides antibody in SARS-CoV-2-infected human sera in a Thai hospital: Rapid serological screening56
Enhancement of the antibiotic activity mediated by the essential oil of Ocotea odorifera (VELL) ROWHER and safrole association54
Assessing beneficial or side effects of COVID-vaccinations requires personal rather than electronic investigations54
Not all respiratory infections were SARS-CoV-2 during the pandemic, analysis in a clinic on the Colombian Caribbean coast53
Treatment of multidrug-resistant Pseudomonas aeruginosa bacteremia using ceftolozane-tazobactam-based or colistin-based antibiotic regimens: A multicenter retrospective study53
COVID-19 diagnosis and severity detection from CT-images using transfer learning and back propagation neural network50
Emergence and dissemination of monkeypox, an intimidating global public health problem44
Uncovering the impact of SARS-CoV2 spike protein variants on human receptors: A molecular dynamics docking and simulation approach44
Post-viral mental health sequelae in infected persons associated with COVID-19 and previous epidemics and pandemics: Systematic review and meta-analysis of prevalence estimates43
Clinical outcomes of nirmatrelvir-ritonavir use in pregnant women during the Omicron wave of the coronavirus disease 2019 pandemic43
Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis41
Perceptions, precautions, and vaccine acceptance related to monkeypox in the public in China: A cross-sectional survey40
0.12526082992554